Category : Search result: pharmaceutical competition


Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board

Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.

Malinin Breaks World Record at Skate Canada

American figure skating sensation Ilia Malinin delivers breathtaking performance, breaking world record score to claim Skate Canada International gold medal in Vancouver.

Top FDA Drug Official Resigns Amid Federal Probe

The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.

Kimberly-Clark Buys Tylenol Maker in $48.7B Deal

In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.

Malinin's Skate Canada win makes him Olympic favorite

American figure skating sensation Ilia Malinin delivers breathtaking performance at Skate Canada International, landing quadruple jumps with ease and establishing himself as the athlete to beat heading toward the 2026 Winter Olympics.

Blood Pressure Medication Recall Over Cancer Risk

Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.

Cenovus-MEG Energy Deal Delayed Over Regulatory Inquiry

A crucial shareholder meeting to approve Cenovus Energy's $3.8 billion acquisition of MEG Energy has been postponed amid regulatory scrutiny from Canadian authorities, creating uncertainty in Alberta's oil sands sector.

Ariana Grande: Why All Singers Are Equals

Ariana Grande opens up about her refreshing perspective on competition in the music industry, revealing why she believes all artists are on the same team.

Boehringer Ingelheim Licenses Novel Autoimmune Treatment

Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.

Page 4 of 4